Follow the FDA advisory panel meeting on the J&J Covid vaccine booster

During Thursday’s online meeting to discuss Moderna’s application for a booster shot, the question — actually questions — that will be put to the committee during today’s discussion about the J&J application was temporarily posted by mistake. Nowhere among them was a question about whether J&J vaccine recipients ought to get a heterologous boost, in other words a boost with a different vaccine.